Events Search and Views Navigation
January 2019
ECRAID-Plan Kick-off meeting
The European Clinical Research Alliance on Infectious Diseases (ECRAID) focuses on two major challenges: emerging infectious diseases (EID) with epidemic or pandemic potential, caused by new or re-emerging pathogens, and antimicrobial resistance (AMR). This meeting aims to bring together the ECRAID-Plan Project Consortium, Working Group, and key stakeholders to constructively discuss ECRAID and its sustainable solutions to protect Europe, and beyond, from AMR and EID threats over the long-term. This is a closed meeting. Kevin Outterson, Executive Director of CARB-X, will…
Find out more »REVIVE Webinar: Clinical development for non-developers Part 3: Antibacterial Drug Enhancer Combinations and Non-traditional Products
On the 29th of January 2019, Ian Friedland, Sumathi Nambiar, Mair Powell, and David Shlaes will join us for a live webinar about antibacterial drug enhancer combinations and non-traditional products. Following their short presentations, the speakers will be available on the line to respond to your questions.
Find out more »March 2019
The Economist Antimicrobial Resistance Summit – Preventing an Antibiotic Apocalypse
Join 120+ health policy leaders, academics and other experts across the industry for a frank discussion to catalyse progress in bringing AMR under control, before it is too late. A series of expert panel discussions will dig into the topics that matter the most, using the convening power of The Economist brand to get the right people working together. Speakers include Kevin Outterson, Executive Director of CARB-X.
Find out more »April 2019
19th World Vaccine Congress
Research, Development, And Strategic Partnership for the Global Vaccine Industry Presentation by Barry Eisenstein, Chair of the CARB-X Advisory Board
Find out more »June 2019
AMR Summit
Additional details to follow.
Find out more »